These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9641495)

  • 1. Heterogeneity of guanylyl cyclase C expressed by human colorectal cancer cell lines in vitro.
    Waldman SA; Barber M; Pearlman J; Park J; George R; Parkinson SJ
    Cancer Epidemiol Biomarkers Prev; 1998 Jun; 7(6):505-14. PubMed ID: 9641495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guanylyl cyclase C: a molecular marker for staging and postoperative surveillance of patients with colorectal cancer.
    Frick GS; Pitari GM; Weinberg DS; Hyslop T; Schulz S; Waldman SA
    Expert Rev Mol Diagn; 2005 Sep; 5(5):701-13. PubMed ID: 16149873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A validated quantitative assay to detect occult micrometastases by reverse transcriptase-polymerase chain reaction of guanylyl cyclase C in patients with colorectal cancer.
    Schulz S; Hyslop T; Haaf J; Bonaccorso C; Nielsen K; Witek ME; Birbe R; Palazzo J; Weinberg D; Waldman SA
    Clin Cancer Res; 2006 Aug; 12(15):4545-52. PubMed ID: 16899600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guanylyl cyclase C as a reliable immunohistochemical marker and its ligand Escherichia coli heat-stable enterotoxin as a potential protein-delivering vehicle for colorectal cancer cells.
    Buc E; Vartanian MD; Darcha C; Déchelotte P; Pezet D
    Eur J Cancer; 2005 Jul; 41(11):1618-27. PubMed ID: 15919201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of cytokeratins 19/20 and guanylyl cyclase C in peripheral blood of colorectal cancer patients.
    Bustin SA; Gyselman VG; Williams NS; Dorudi S
    Br J Cancer; 1999 Apr; 79(11-12):1813-20. PubMed ID: 10206298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.
    Guadagni F; Kantor J; Aloe S; Carone MD; Spila A; D'Alessandro R; Abbolito MR; Cosimelli M; Graziano F; Carboni F; Carlini S; Perri P; Sciarretta F; Greiner JW; Kashmiri SV; Steinberg SM; Roselli M; Schlom J
    Cancer Res; 2001 Mar; 61(6):2523-32. PubMed ID: 11289125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guanylyl cyclase C suppresses intestinal tumorigenesis by restricting proliferation and maintaining genomic integrity.
    Li P; Schulz S; Bombonati A; Palazzo JP; Hyslop TM; Xu Y; Baran AA; Siracusa LD; Pitari GM; Waldman SA
    Gastroenterology; 2007 Aug; 133(2):599-607. PubMed ID: 17681179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor angiogenesis and its possible role in intravasation of colorectal epithelial cells.
    Tien YW; Chang KJ; Jeng YM; Lee PH; Wu MS; Lin JT; Hsu SM
    Clin Cancer Res; 2001 Jun; 7(6):1627-32. PubMed ID: 11410499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guanylyl cyclase C is a selective marker for metastatic colorectal tumors in human extraintestinal tissues.
    Carrithers SL; Barber MT; Biswas S; Parkinson SJ; Park PK; Goldstein SD; Waldman SA
    Proc Natl Acad Sci U S A; 1996 Dec; 93(25):14827-32. PubMed ID: 8962140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
    Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
    J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guanylyl cyclase C is a marker of intestinal metaplasia, dysplasia, and adenocarcinoma of the gastrointestinal tract.
    Birbe R; Palazzo JP; Walters R; Weinberg D; Schulz S; Waldman SA
    Hum Pathol; 2005 Feb; 36(2):170-9. PubMed ID: 15754294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guanylyl cyclase C as a biomarker for targeted imaging and therapy of metastatic colorectal cancer.
    Chang C; Marszlowicz G; Waldman Z; Li P; Snook AE; Lin JE; Schulz S; Waldman SA
    Biomark Med; 2009 Feb; 3(1):33-45. PubMed ID: 20477494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analytical performance of a qRT-PCR assay to detect guanylyl cyclase C in FFPE lymph nodes of patients with colon cancer.
    Beaulieu M; Desaulniers M; Bertrand N; Deschesnes RG; Beaudry G; Garon G; Haince JF; Houde M; Holzer TJ
    Diagn Mol Pathol; 2010 Mar; 19(1):20-7. PubMed ID: 20186008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A splice variant of the transcript for guanylyl cyclase C is expressed in human colon and colorectal cancer cells.
    Pearlman JM; Prawer SP; Barber MT; Parkinson SJ; Schulz S; Park J; Zook M; Waldman SA
    Dig Dis Sci; 2000 Feb; 45(2):298-305. PubMed ID: 10711442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigations for a multi-marker RT-PCR to improve sensitivity of disseminated tumor cell detection.
    Vlems FA; Diepstra JH; Cornelissen IM; Ligtenberg MJ; Wobbes T; Punt CJ; van Krieken JH; Ruers TJ; van Muijen GN
    Anticancer Res; 2003; 23(1A):179-86. PubMed ID: 12680210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of functional prolactin and its receptor in human colorectal cancer.
    Otte JM; Otte C; Beckedorf S; Schmitz F; Vonderhaar BK; Fölsch UR; Kloehn S; Herzig KH; Mönig H
    Int J Colorectal Dis; 2003 Jan; 18(1):86-94. PubMed ID: 12458387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topological mimicry and epitope duplication in the guanylyl cyclase C receptor.
    Nandi A; Suguna K; Surolia A; Visweswariah SS
    Protein Sci; 1998 Oct; 7(10):2175-83. PubMed ID: 9792105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of CK20 gene and protein expression in colorectal cancer by RT-PCR and immunohistochemistry reveals inter- and intratumour heterogeneity.
    Lassmann S; Bauer M; Soong R; Schreglmann J; Tabiti K; Nährig J; Rüger R; Höfler H; Werner M
    J Pathol; 2002 Oct; 198(2):198-206. PubMed ID: 12237879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ectopic expression of guanylyl cyclase C in adenocarcinomas of the esophagus and stomach.
    Park J; Schulz S; Haaf J; Kairys JC; Waldman SA
    Cancer Epidemiol Biomarkers Prev; 2002 Aug; 11(8):739-44. PubMed ID: 12163327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ectopic expression of guanylyl cyclase C in gastric cancer as a potential biomarker and therapeutic target.
    Mao ZB; Zhang JF; Xu Z; Zhu HJ; Zhang JG; Pan ZP; Xiao F; Yang JL
    J Dig Dis; 2009 Nov; 10(4):272-85. PubMed ID: 19906106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.